Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 9 of 50 for:    "Prosthetic Joint Infection"

Synovial Aspiration and Serological Testing in Two-stage Revision Arthroplasty of Prosthetic Joint Infection (SyPJI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03038464
Recruitment Status : Unknown
Verified January 2017 by Harrasser, Technische Universität München.
Recruitment status was:  Recruiting
First Posted : January 31, 2017
Last Update Posted : April 25, 2017
Sponsor:
Information provided by (Responsible Party):
Harrasser, Technische Universität München

Brief Summary:

The two-stage protocol is gold standard in terms of infection control treating prosthetic joint infections of total hip and total knee arthroplasty. The antibiotic pause for diagnostic reasons before reconstruction (stage two) is discussed concerning persistence of infection and development of resistant bacterial strains. Serological markers and synovial analysis are common use to exclude persistence of infection.

The investigators therefore asked 1) is the serological testing of c-reactive protein and leukocytes a valuable tool to predict a persistence of infection and 2) what is the role of synovial aspiration of PMMA Spacers on hip and knee joints.


Condition or disease Intervention/treatment
Diagnosis Prosthetic Joint Infection Diagnostic Test: Synovial biopsy

Layout table for study information
Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Benefit of Synovial Aspiration and Serological Testing in Two-stage Revision Arthroplasty of Prosthetic Joint Infection
Actual Study Start Date : November 1, 2016
Estimated Primary Completion Date : April 1, 2019
Estimated Study Completion Date : May 1, 2019

Resource links provided by the National Library of Medicine



Intervention Details:
  • Diagnostic Test: Synovial biopsy
    Biopsy of jint prior reimplantation of new joint prosthesis


Primary Outcome Measures :
  1. Reinfection rate [ Time Frame: 2 years ]
    Reinfection rate after reimplantation of joint prosthesis



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients with periprostheitc joint infection
Criteria

Inclusion Criteria:

  • Patients with periprostheitc joint infection

Exclusion Criteria:

  • Reinfection in history

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03038464


Contacts
Layout table for location contacts
Contact: norbert harrasser 15232716657 norbert.harrasser@gmx.net

Locations
Layout table for location information
Germany
Klinikum rechts der Isar Recruiting
Munich, Bavaria, Germany, 81675
Contact: Norbert Harrasser, DR.    00498941405229    norbert.harrasser@gmx.net   
Contact: Ingo Banke, Dr.    00498941405284    ingo@banke.eu   
Sponsors and Collaborators
Technische Universität München

Layout table for additonal information
Responsible Party: Harrasser, Principal Investigator, Technische Universität München
ClinicalTrials.gov Identifier: NCT03038464     History of Changes
Other Study ID Numbers: 445/21
First Posted: January 31, 2017    Key Record Dates
Last Update Posted: April 25, 2017
Last Verified: January 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Infection
Communicable Diseases
Arthritis, Infectious
Arthritis
Joint Diseases
Musculoskeletal Diseases